Latest King's College Stories
The dementia drug donepezil (Aricept), already widely used to treat mild to moderate Alzheimer's disease, can also help in moderate to severe patients, according to a report funded by the UK Medical Research Council (MRC) and the Alzheimer's Society.
Stroke is the leading cause of death in people over 65 in low- and middle-income countries.
A team of UK researchers claims to have put forth the first ever experimental evidence in support of a long-standing theory about how biological patterns such as a leopard's spots or a tiger's stripes are formed.
Scientists at King's College London and the National Diabetes Centre (Sri Lanka) have found evidence of a high number of risk factors for type 2 diabetes among the young urban population in Sri Lanka.
Tuberculosis patients may receive treatments in the future according to what version they have of a single 'Goldilocks' gene.
The London Organizing Committee of the Olympic and Paralympic Games (LOCOG) last Thursday unveiled the WADA accredited anti-doping laboratory, which will operate during the London 2012 Games.
Although around two thirds of us would prefer to die at home, in the developed world the trend in recent years has been for the majority to spend their final days in an institutional setting.
Treating 'brain tsunamis' or 'killer waves' could stop many victims of major head injury from suffering additional brain damage, a study published in Lancet Neurology has found.
Researchers from King's College London have produced the first animal product-free clinical grade human embryonic stem cell lines.
Stem cell scientists at King's College London will today (Tuesday 6 December) announce they have submitted to the UK Stem Cell Bank (UKSCB) their first clinical grade human embryonic stem (hES) cell lines that are free from animal-derived products, known as 'xeno-free' stem cells.
- A transitional zone between two communities containing the characteristic species of each.